| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |